ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,146Medicare Part D Prescriptions Filled, Including Refills

Rank: 99 out of 663

$431K Total Retail Price of All Prescriptions

Rank: 103 out of 663

392 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 392 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

16% of this provider’s 392 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,187 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 528 477 1 3
LISINOPRIL 331 316 2 2
SIMVASTATIN 331 295 2 1
OMEPRAZOLE 299 275 4 4
AMLODIPINE BESYLATE 275 261 5 5
HYDROCODONE-ACETAMINOPHEN 215 203 S3 6 6
WARFARIN SODIUM 194 179 7 8
ATENOLOL 191 180 8 10
HYDROCHLOROTHIAZIDE 189 152 9 12
METFORMIN HCL 180 151 10 9
ATORVASTATIN CALCIUM 156 137 11 13
LOSARTAN POTASSIUM 133 122 12 14
DONEPEZIL HCL 118 118 13 40
ZOLPIDEM TARTRATE 115 99 14 16
PRAVASTATIN SODIUM 109 90 15 21
FUROSEMIDE 107 103 16 7
GLIPIZIDE 104 103 17 29
POTASSIUM CHLORIDE 103 85 18 23
GABAPENTIN 100 100 19 20
ALENDRONATE SODIUM 98 98 20 15
OXYCODONE-ACETAMINOPHEN 94 67 S2 21 26
TAMSULOSIN HCL 92 81 22 24
SERTRALINE HCL 80 76 23 35
CITALOPRAM HBR 79 64 24 18
AZITHROMYCIN 78 61 25 64
METOPROLOL TARTRATE 69 53 26 11
PREDNISONE 67 59 27 39
LOVASTATIN 63 62 28 30
CEPHALEXIN 63 57 28 119
CYCLOBENZAPRINE HCL 59 38 R 30 71
PANTOPRAZOLE SODIUM 59 50 30 45
FLUTICASONE PROPIONATE 56 53 32 27
KLOR-CON M20 56 49 32 70
CELEBREX 54 51 34 85
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 48 35 22
JANUVIA 53 50 35 78
LANTUS 52 39 37 48
PAROXETINE HCL 50 48 38 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.